Neurocrine Bioscience buy Bank of America Co.
Start price
07.02.25
/
50%
€125.40
Target price
07.02.26
€172.66
Performance (%)
-5.94%
End price
08.02.26
€117.95
Summary
This prediction ended on 08.02.26 with a price of €117.95. With a performance of -5.94%, the BUY prediction for Neurocrine Bioscience by Bank_of_America_Co_ closed slightly in the red. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 3.309% | 3.309% | 11.443% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Bank of America Co. from $184.00 to $179.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten